Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 3000 Wockhardt Associates from 21 different nationalities globally. Its operations include the production and sale of pharmaceutical and biopharmaceutical formulations, Active Pharmaceutical Ingredients (APIs), and vaccines. It has 12 manufacturing facilities and 3 research centers.
Wockhardt is a multinational biotechnology and pharmaceutical company that offers high-quality, reasonably priced medications to promote global health. It is the top research-based worldwide healthcare company in India, having a strong presence in the biotechnology and pharmaceutical industries as well as a network of cutting-edge super specialty hospitals.

Wockhardt is based in Mumbai, India, and operates fully in the USA, UK, Ireland, and France. Additionally, it is present in emerging markets such as those in Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon, Kuwait, Brazil, Mexico, Vietnam, and the Philippines.

The main focus of Wockhardt is innovation. It makes use of science and technology to create medications and other goods that enhance millions of people’s lives by promoting better health.

Wockhardt wants to see the globe become healthier. Its strategy goal of “More & More with Less & Less” has evolved into novel perspectives, a fresh path toward expansion, patient-centered medical advancements, and ongoing value for all stakeholders.